Femasys, Inc. (FEMY)
0.8666
+0.04
(+4.84%)
USD |
NASDAQ |
Dec 10, 16:00
0.8666
0.00 (0.00%)
After-Hours: 16:09
Femasys EPS Diluted (Quarterly): -0.1023 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quantum-Si, Inc. | -0.1708 |
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.195M |
| Revenue (Quarterly) | 0.7294M |
| Total Expenses (Quarterly) | 4.924M |
| Enterprise Value | 52.20M |
| Gross Profit Margin (Quarterly) | 30.78% |
| Profit Margin (Quarterly) | -575.1% |
| Earnings Yield | -83.12% |
| Normalized Earnings Yield | -83.12 |